Extracorporeal model for study of factors affecting thrombus formation. 1975

A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak

Factors determining thrombus formation on a foreign surface were studied with the use of plastic flow chambers introduced into extracorporeal shunts. Silicone rubber shunts, joining the carotid artery and jugular vein, were implanted in dogs and remained patent for several weeks. The flow chamber geometry consisted of a 4.8 mm diameter straight tube having a 3.2 X 3.2 mm circumferential cavity in the wall. Chambers were introduced sequentially into the shunts for exposure times of 10 to 30 minutes and regulated blood flow rates of 100 to 400 ml/min. The dry weight of thrombus accumulated in the chamber (5 to 50 mg) was found to increase with exposure time up to 20 minutes and to decrease with increasing flow rate. Various components of the process of thrombus formation were altered by the administration of acetylsalicylic acid, heparin and lysozyme, used alone and in pairs. Heparin was found to be the most effective antithrombotic agent, dry weights of accumulated thrombus being on the order of 50 percent lower when compared to control values. The efficacy of heparin was found to be unaffected by the presence of aspirin and lysozyme, which themselves were not effective antithrombotic agents under the conditions of these experiments. The technique described here may provide a useful animal model for studying the influence of blood flow and different biomaterials on thrombus formation.

UI MeSH Term Description Entries
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005112 Extracorporeal Circulation Diversion of blood flow through a circuit located outside the body but continuous with the bodily circulation. Circulation, Extracorporeal,Circulations, Extracorporeal,Extracorporeal Circulations
D005549 Foreign-Body Reaction Chronic inflammation and granuloma formation around irritating foreign bodies. Foreign Body Reaction,Reaction, Foreign-Body
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin

Related Publications

A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
October 1972, Annals of the New York Academy of Sciences,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
March 1976, Annals of biomedical engineering,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
June 1927, The Journal of experimental medicine,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
March 1994, Giornale italiano di cardiologia,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
March 1994, Giornale italiano di cardiologia,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
March 1979, Journal of biomedical materials research,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
January 2005, Advances in experimental medicine and biology,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
March 2002, Pharmacology & toxicology,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
November 2020, CJC open,
A M Benis, and H L Nossel, and L M Aledort, and R M Koffsky, and J F Stevenson, and E F Leonard, and H Shiang, and R S Litwak
January 2017, PLoS computational biology,
Copied contents to your clipboard!